CIHR funding boosts Queen's research into breast cancer treatment
2010 August
"We have been working on these projects for several years and are delighted that both grants were
renewed in the last Canadian Institute for Health Research (CIHR) competition," says Dr. Greer.
The researchers in Dr. Greer's lab are looking at the impact of two enzymes - Fer and calpain - on tumour growth.
In previous studies at Queen's Cancer Research Institute, Dr. Greer and his research team have
shown that inhibiting these enzymes slows cancer growth. Further research is aimed at a deeper
understanding of how Fer and calpain contribute to causing tumours, and at developing
new drugs to target the enzymes in cancer treatment.
3
Peter Greer (Pathology and Molecular Medicine) has received $1.6 million for two research projects
aimed at developing new treatments to slow tumour growth in breast cancer.